149 related articles for article (PubMed ID: 26317995)
1. Glycemic Control with Thiazolidinedione Is Associated with Fracture of T2DM Patients.
Chen HH; Horng MH; Yeh SY; Lin IC; Yeh CJ; Muo CH; Sung FC; Kao CH
PLoS One; 2015; 10(8):e0135530. PubMed ID: 26317995
[TBL] [Abstract][Full Text] [Related]
2. Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs?
Bazelier MT; Gallagher AM; van Staa TP; Cooper C; Leufkens HG; Vestergaard P; de Vries F
Pharmacoepidemiol Drug Saf; 2012 May; 21(5):507-14. PubMed ID: 22392882
[TBL] [Abstract][Full Text] [Related]
3. Use of thiazolidinediones and fracture risk.
Meier C; Kraenzlin ME; Bodmer M; Jick SS; Jick H; Meier CR
Arch Intern Med; 2008 Apr; 168(8):820-5. PubMed ID: 18443256
[TBL] [Abstract][Full Text] [Related]
4. Risk of fracture with thiazolidinediones: disease or drugs?
Bazelier MT; Vestergaard P; Gallagher AM; van Staa TP; Cooper C; Leufkens HG; de Vries F
Calcif Tissue Int; 2012 Jun; 90(6):450-7. PubMed ID: 22488176
[TBL] [Abstract][Full Text] [Related]
5. Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes.
Aubert RE; Herrera V; Chen W; Haffner SM; Pendergrass M
Diabetes Obes Metab; 2010 Aug; 12(8):716-21. PubMed ID: 20590749
[TBL] [Abstract][Full Text] [Related]
6. [Do thiazolidinediones harm skeletal integrity?].
Takeuchi Y
Clin Calcium; 2008 May; 18(5):650-5. PubMed ID: 18445884
[TBL] [Abstract][Full Text] [Related]
7. Thiazolidinediones and fractures: evidence from translating research into action for diabetes.
Bilik D; McEwen LN; Brown MB; Pomeroy NE; Kim C; Asao K; Crosson JC; Duru OK; Ferrara A; Hsiao VC; Karter AJ; Lee PG; Marrero DG; Selby JV; Subramanian U; Herman WH
J Clin Endocrinol Metab; 2010 Oct; 95(10):4560-5. PubMed ID: 20631021
[TBL] [Abstract][Full Text] [Related]
8. Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus.
Chang CH; Lin JW; Wu LC; Lai MS; Chuang LM; Chan KA
Hepatology; 2012 May; 55(5):1462-72. PubMed ID: 22135104
[TBL] [Abstract][Full Text] [Related]
9. The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis.
Koro CE; Sowell MO; Stender M; Qizilbash N
Clin Ther; 2008 Mar; 30(3):535-42. PubMed ID: 18405791
[TBL] [Abstract][Full Text] [Related]
10. [Thiazolidinediones and skeletal health].
Meier C; Bodmer M; Meier CR; Kraenzlin ME
Rev Med Suisse; 2009 Jun; 5(207):1309-10, 1312-3. PubMed ID: 19626930
[TBL] [Abstract][Full Text] [Related]
11. Distal upper and lower limb fractures associated with thiazolidinedione use.
Jones SG; Momin SR; Good MW; Shea TK; Patric K
Am J Manag Care; 2009 Aug; 15(8):491-6. PubMed ID: 19670952
[TBL] [Abstract][Full Text] [Related]
12. Thiazolidinediones and the risk of incident congestive heart failure among patients with type 2 diabetes mellitus.
Filion KB; Joseph L; Boivin JF; Suissa S; Brophy JM
Pharmacoepidemiol Drug Saf; 2011 Aug; 20(8):785-96. PubMed ID: 21671441
[TBL] [Abstract][Full Text] [Related]
13. Thiazolidinedione-induced skeletal fragility--mechanisms and implications.
Grey A
Diabetes Obes Metab; 2009 Apr; 11(4):275-84. PubMed ID: 18671797
[TBL] [Abstract][Full Text] [Related]
14. Thiazolidinediones and the risk of incident strokes in patients with type 2 diabetes: a nested case-control study.
Azoulay L; Schneider-Lindner V; Dell'aniello S; Filion KB; Suissa S
Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):343-50. PubMed ID: 19998318
[TBL] [Abstract][Full Text] [Related]
15. Thiazolidinedione treatment decreases bone mineral density in type 2 diabetic men.
Yaturu S; Bryant B; Jain SK
Diabetes Care; 2007 Jun; 30(6):1574-6. PubMed ID: 17363747
[No Abstract] [Full Text] [Related]
16. Time-dependent risk of fracture in adults with type 2 diabetes receiving anti-diabetic drug: A one-stage network meta-analysis.
Shen Y; Shi Q; Zou X; Meng W; Tian H; Du L; Li S
Diabetes Metab Res Rev; 2024 Feb; 40(2):e3780. PubMed ID: 38367257
[TBL] [Abstract][Full Text] [Related]
17. Thiazolidinediones and fractures in men and women.
Dormuth CR; Carney G; Carleton B; Bassett K; Wright JM
Arch Intern Med; 2009 Aug; 169(15):1395-402. PubMed ID: 19667303
[TBL] [Abstract][Full Text] [Related]
18. Cancer and bone fractures in observational follow-up of the RECORD study.
Jones NP; Curtis PS; Home PD
Acta Diabetol; 2015 Jun; 52(3):539-46. PubMed ID: 25524432
[TBL] [Abstract][Full Text] [Related]
19. Bone as a target of type 2 diabetes treatment.
Lecka-Czernik B
Curr Opin Investig Drugs; 2009 Oct; 10(10):1085-90. PubMed ID: 19777397
[TBL] [Abstract][Full Text] [Related]
20. Cancer risks in thiazolidinedione users compared to other anti-diabetic agents.
Koro C; Barrett S; Qizilbash N
Pharmacoepidemiol Drug Saf; 2007 May; 16(5):485-92. PubMed ID: 17192841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]